570 related articles for article (PubMed ID: 22525471)
141. Overall response of both intrahepatic tumor and portal vein tumor thrombosis is a good prognostic factor for hepatocellular carcinoma patients receiving concurrent chemoradiotherapy.
Choi Y; Kim JW; Cha H; Han KH; Seong J
J Radiat Res; 2014 Jan; 55(1):113-20. PubMed ID: 23772086
[TBL] [Abstract][Full Text] [Related]
142. Treatment response, survival and safety profile of transarterial chemoembolization using different sizes of drug-eluting beads in hepatocellular carcinoma patients with portal vein tumor thrombus.
Lyu T; Yao H; Wang J; Song L; Tong X; Zou Y
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101819. PubMed ID: 34619365
[TBL] [Abstract][Full Text] [Related]
143. Genetic variants in the EPCAM gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma with portal vein tumor thrombus.
Yu X; Ge N; Guo X; Shen S; Liang J; Huang X; Wan S; Xing J; Huang Q; Yang Y
PLoS One; 2014; 9(4):e93416. PubMed ID: 24718422
[TBL] [Abstract][Full Text] [Related]
144. Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma.
Yamada K; Izaki K; Sugimoto K; Mayahara H; Morita Y; Yoden E; Matsumoto S; Soejima T; Sugimura K
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):113-9. PubMed ID: 12909223
[TBL] [Abstract][Full Text] [Related]
145. The impact of sphingosine kinase 1 on the prognosis of hepatocellular carcinoma patients with portal vein tumor thrombus.
Shi J; He YY; Sun JX; Guo WX; Li N; Xue J; Cheng SQ
Ann Hepatol; 2015; 14(2):198-206. PubMed ID: 25671829
[TBL] [Abstract][Full Text] [Related]
146. Pilot study of local radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma.
Yamada K; Soejima T; Sugimoto K; Mayahara H; Izaki K; Sasaki R; Maruta T; Matsumoto S; Hirota S; Sugimura K
Jpn J Clin Oncol; 2001 Apr; 31(4):147-52. PubMed ID: 11386460
[TBL] [Abstract][Full Text] [Related]
147. Outcome of transarterial chemoembolization in Egyptian patients with hepatocellular carcinoma and branch portal vein thrombosis.
Abdella H; Shaker MK; Montasser IF; Sobhi M; Aly H; Sayed A; Saleh S; El Dorry A
Indian J Gastroenterol; 2018 Mar; 37(2):127-132. PubMed ID: 29532323
[TBL] [Abstract][Full Text] [Related]
148. Efficiency of regional functional liver volume assessment using Gd-EOB-DTPA-enhanced magnetic resonance imaging for hepatocellular carcinoma with portal vein tumor thrombus.
Araki K; Harimoto N; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Watanabe A; Kubo N; Tsushima Y; Shirabe K
Surg Today; 2020 Nov; 50(11):1496-1506. PubMed ID: 32613270
[TBL] [Abstract][Full Text] [Related]
149. Adaptation of lenvatinib treatment in patients with hepatocellular carcinoma and portal vein tumor thrombosis.
Mukozu T; Nagai H; Matsui D; Mohri K; Watanabe G; Yoshimine N; Amanuma M; Kobayashi K; Ogino Y; Matsukiyo Y; Matsui T; Daido Y; Wakui N; Shinohara M; Momiyama K; Higai K; Igarashi Y
Cancer Chemother Pharmacol; 2022 Jan; 89(1):11-20. PubMed ID: 34628536
[TBL] [Abstract][Full Text] [Related]
150. Factors influencing the short-term and long-term survival of hepatocellular carcinoma patients with portal vein tumor thrombosis who underwent chemoembolization.
Chen KL; Gao J
World J Gastroenterol; 2021 Apr; 27(13):1330-1340. PubMed ID: 33833486
[TBL] [Abstract][Full Text] [Related]
151. Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis.
Nakazawa T; Hidaka H; Shibuya A; Okuwaki Y; Tanaka Y; Takada J; Minamino T; Watanabe M; Kokubu S; Koizumi W
BMC Gastroenterol; 2014 May; 14():84. PubMed ID: 24886354
[TBL] [Abstract][Full Text] [Related]
152. Preoperative ultrasound features as prognostic factors for patients with hepatocellular carcinoma.
Shen ZY; Xia GL; Hu B; Xie YG; Wu MF
Radiol Med; 2015 Jun; 120(6):504-10. PubMed ID: 25572544
[TBL] [Abstract][Full Text] [Related]
153. Adjuvant intraportal venous chemotherapy for patients with hepatocellular carcinoma and portal vein tumor thrombi following hepatectomy plus portal thrombectomy.
Liang LJ; Hu WJ; Yin XY; Zhou Q; Peng BG; Li DM; Lu MD
World J Surg; 2008 Apr; 32(4):627-31. PubMed ID: 18228094
[TBL] [Abstract][Full Text] [Related]
154. Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a meta-analysis.
Xue TC; Xie XY; Zhang L; Yin X; Zhang BH; Ren ZG
BMC Gastroenterol; 2013 Apr; 13():60. PubMed ID: 23566041
[TBL] [Abstract][Full Text] [Related]
155. Efficacy of therapy for hepatocellular carcinoma with portal vein tumor thrombus: chemoembolization and stent combined with iodine-125 seed.
Chuan-Xing L; Xu H; Bao-Shan H; Yong L; Pei-Jian S; Xian-Yi Y; Xiao-Ning L; Li-Gong L
Cancer Biol Ther; 2011 Nov; 12(10):865-71. PubMed ID: 22037354
[TBL] [Abstract][Full Text] [Related]
156. Comprehensive review of hepatocellular carcinoma with portal vein tumor thrombus: State of art and future perspectives.
Gavriilidis P; Pawlik TM; Azoulay D
Hepatobiliary Pancreat Dis Int; 2024 Jun; 23(3):221-227. PubMed ID: 37903712
[TBL] [Abstract][Full Text] [Related]
157. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus.
Zhang YF; Wei W; Guo ZX; Wang JH; Shi M; Guo RP
Jpn J Clin Oncol; 2015 Sep; 45(9):837-43. PubMed ID: 26079139
[TBL] [Abstract][Full Text] [Related]
158. Risk factors of poor prognosis and portal vein tumor thrombosis after curative resection of solitary hepatocellular carcinoma.
Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
Hepatobiliary Pancreat Dis Int; 2013 Feb; 12(1):68-73. PubMed ID: 23392801
[TBL] [Abstract][Full Text] [Related]
159. Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha-fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma.
Gon H; Kido M; Tanaka M; Kinoshita H; Komatsu S; Tsugawa D; Awazu M; Toyama H; Matsumoto I; Itoh T; Fukumoto T
Surgery; 2018 Nov; 164(5):1014-1022. PubMed ID: 30093272
[TBL] [Abstract][Full Text] [Related]
160. Prognostic Significance of Concurrent Hypovascular and Hypervascular Nodules in Patients with Hepatocellular Carcinoma.
Ogasawara S; Chiba T; Motoyama T; Kanogawa N; Saito T; Shinozaki Y; Suzuki E; Ooka Y; Tawada A; Kato H; Okabe S; Kanai F; Yoshikawa M; Yokosuka O
PLoS One; 2016; 11(9):e0163119. PubMed ID: 27649084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
